These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 8105785

  • 1. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P, Aurich R, Petzold U.
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [Abstract] [Full Text] [Related]

  • 2. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H, Aurich R, Petzold U, Dorow P, Enzmann H, Gering R, Köchy HP, Philippe A, Renz W, Wendenburg G.
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W, Diez Crespo CD, Bähre M.
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [Abstract] [Full Text] [Related]

  • 5. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P, Kaliner MA, Wheeler WJ.
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [Abstract] [Full Text] [Related]

  • 6. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
    Gastpar H, Dorow P, Aurich R, Petzold U.
    Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I, Jaúregui I, Basomba A, Cadahia A, Feo F, García JJ, Gonzalo MA, Luna I, Rubio M, Vázquez M.
    Allergol Immunopathol (Madr); 1998 Jul; 26(1):9-16. PubMed ID: 9585822
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 Aug; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 11. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ, Lund VJ, Harten-Ash VJ.
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [Abstract] [Full Text] [Related]

  • 12. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
    Arcimowicz M, Samoliński B, Zawisza E.
    Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.
    LaForce C, Dockhorn RJ, Prenner BM, Chu TJ, Kraemer MJ, Widlitz MD, D'Eletto TA, Freitag JJ.
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):181-8. PubMed ID: 8595539
    [Abstract] [Full Text] [Related]

  • 14. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM, Meltzer EO.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [Abstract] [Full Text] [Related]

  • 15. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
    Herman D, Garay R, Le Gal M.
    Int J Pediatr Otorhinolaryngol; 1997 Feb 14; 39(1):1-8. PubMed ID: 9051434
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug 14; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups.
    Ann Allergy Asthma Immunol; 2001 Jan 14; 86(1):28-35. PubMed ID: 11206234
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W, Prenner B, Corren J, Wheeler W.
    Ann Allergy Asthma Immunol; 2007 Sep 14; 99(3):267-72. PubMed ID: 17910331
    [Abstract] [Full Text] [Related]

  • 19. Azelastine nasal spray in the management of seasonal allergic rhinitis.
    Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ.
    Ann Allergy; 1994 Apr 14; 72(4):354-9. PubMed ID: 7908778
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ, Horak F, Nirnberger G, Rehn D.
    Arzneimittelforschung; 1996 Aug 14; 46(8):794-9. PubMed ID: 9125281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.